share_log

平安好醫生:截至2024年2月29日止月份之股份發行人的證券變動月報表

PA GOODDOCTOR: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 1 03:37
Summary by Moomoo AI
平安健康醫療科技有限公司(平安好医生)於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年2月29日的股份變動情況。報告顯示,公司的法定/註冊股本及已發行股份在報告期間內均無變動,法定/註冊股本結存為10,000,000,000股,面值為0.000005美元,總額為50,000美元。此外,報告中確認了公司在本月發行的證券已獲得董事會的正式授權,並且已履行了所有上市前的法定要求。執行董事李斗為本次報告的呈交者。
平安健康醫療科技有限公司(平安好医生)於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年2月29日的股份變動情況。報告顯示,公司的法定/註冊股本及已發行股份在報告期間內均無變動,法定/註冊股本結存為10,000,000,000股,面值為0.000005美元,總額為50,000美元。此外,報告中確認了公司在本月發行的證券已獲得董事會的正式授權,並且已履行了所有上市前的法定要求。執行董事李斗為本次報告的呈交者。
Ping An Health Medical Technology Co., Ltd. (Dr. Ping An Ho) filed an updated Securities Change Month Report with Hong Kong Trading and Settlement Limited on March 1, 2024, reporting stock changes as of February 29, 2024. THE REPORT SHOWS THAT THE STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES OF THE COMPANY WERE UNCHANGED DURING THE REPORTING PERIOD. THE STATUTORY/REGISTERED SHARE CAPITAL WAS 10,000,000,000 SHARES WITH A FACE VALUE OF USD 0.000005 FOR A TOTAL AMOUNT OF USD 50,000. In addition, the report confirms that the securities issued by the company this month have been formally authorized by the Board of Directors and have met all pre-listing regulatory requirements. Executive Director Li Du is the submitter of this report.
Ping An Health Medical Technology Co., Ltd. (Dr. Ping An Ho) filed an updated Securities Change Month Report with Hong Kong Trading and Settlement Limited on March 1, 2024, reporting stock changes as of February 29, 2024. THE REPORT SHOWS THAT THE STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES OF THE COMPANY WERE UNCHANGED DURING THE REPORTING PERIOD. THE STATUTORY/REGISTERED SHARE CAPITAL WAS 10,000,000,000 SHARES WITH A FACE VALUE OF USD 0.000005 FOR A TOTAL AMOUNT OF USD 50,000. In addition, the report confirms that the securities issued by the company this month have been formally authorized by the Board of Directors and have met all pre-listing regulatory requirements. Executive Director Li Du is the submitter of this report.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more